Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of MBF-015 in Huntington's Disease Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MBF-015 for Huntington disease has completed, reporting on safety, pharmacokinetics, and pharmacodynamics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• MBF-015

Snippet

Sponsor: Medibiofarma S.L. | Conditions: Huntington Disease | Phase 2 | Status: COMPLETED